Romania - romanès - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

fresenius kabi deutschland gmbh - germania - combinatii - sol. perf. - solutii pentru administrare intravenoasa solutii pentru nutritie parenterala

Romania - romanès - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

fresenius kabi deutschland gmbh - germania - combinatii - sol. perf. - solutii pentru administrare intravenoasa solutii pentru nutritie parenterala

Unió Europea - eslovè - EMA (European Medicines Agency)

fresenius kabi deutschland gmbh - busulfan - hematopoetična presaditev izvornih celic - alkil sulfonati - busulfan fresenius kabi sledi ciklofosfamid (bucy2) je navedena kot kondicioniranje zdravljenje pred konvencionalne krvotvornih matičnih celic presaditev (hpct) pri odraslih bolnikih, ko kombinacija se šteje na voljo možnost. busulfan fresenius kabi sledi ciklofosfamid (bucy4) ali melphalan (bumel) je označena kot naprava za zdravljenje pred konvencionalnimi haematopoietic progenitor cell presaditev v pediatričnih bolnikih.

Unió Europea - eslovè - EMA (European Medicines Agency)

fresenius kabi deutschland gmbh - pemetreksed - carcinoma, non-small-cell lung; mesothelioma - antineoplastična sredstva - maligni pleural mesotheliomapemetrexed fresenius kabi v kombinaciji z cisplatin je primerna za zdravljenje kemoterapija naivna bolnikih z unresectable maligni pleural mesothelioma. non-small cell lung cancerpemetrexed fresenius kabi v kombinaciji z cisplatin je označen za prvo linijo zdravljenja bolnikov z lokalno napredno ali metastatskim non-small cell lung cancer razen pretežno skvamoznih celic histologija. pemetrexed fresenius kabi je označen kot monotherapy za vzdrževanje zdravljenje lokalno napredno ali metastatskim non-small cell lung cancer razen pretežno skvamoznih celic histologijo pri bolnikih, katerih bolezen ni napredovala takoj po platinum, ki temelji kemoterapijo. pemetrexed fresenius kabi je označen kot monotherapy na drugi liniji zdravljenja bolnikov z lokalno napredno ali metastatskim non-small cell lung cancer razen pretežno skvamoznih celic histologija.

Unió Europea - anglès - EMA (European Medicines Agency)

fresenius kabi deutschland gmbh - busulfan - hematopoietic stem cell transplantation - alkyl sulfonates - busulfan fresenius kabi followed by cyclophosphamide (bucy2) is indicated as conditioning treatment prior to conventional haematopoietic progenitor cell transplantation (hpct) in adult patients when the combination is considered the best available option.busulfan fresenius kabi followed by cyclophosphamide (bucy4) or melphalan (bumel) is indicated as conditioning treatment prior to conventional haematopoietic progenitor cell transplantation in paediatric patients.

Unió Europea - anglès - EMA (European Medicines Agency)

fresenius kabi deutschland gmbh - pemetrexed - carcinoma, non-small-cell lung; mesothelioma - antineoplastic agents - malignant pleural mesotheliomapemetrexed fresenius kabi in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma.non-small cell lung cancerpemetrexed fresenius kabi in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology.pemetrexed fresenius kabi is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy. pemetrexed fresenius kabi is indicated as monotherapy for the second line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology.

Letònia - letó - Zāļu valsts aģentūra

fresenius kabi deutschland gmbh, germany - kalii chloridum, natrii chloridum - Šķīdums infūzijām - 1,5 mg/9 mg/ml

Letònia - letó - Zāļu valsts aģentūra

fresenius kabi deutschland gmbh, germany - poli - (o-2-hidroksietil) amylum, natrii chloridum - Šķīdums infūzijām - 6%

Romania - romanès - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

fresenius kabi austria gmbh - austria - propofolum - emulsie perf./inj. - 10mg/ml - anestezice generale alte anestezice generale

Romania - romanès - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

fresenius kabi austria gmbh - austria - propofolum - emulsie perf./inj. - 20mg/ml - anestezice generale alte anestezice generale